Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
9.95
-0.31 (-2.97%)
Sep 15, 2025, 4:00 PM EDT - Market closed
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $44.20 million as of September 15, 2025. Its market cap has increased by 30.86% in one year.
Market Cap
44.20M
Enterprise Value
39.05M
1-Year Change
30.86%
Ranking
Category
Stock Price
$9.95
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $44.20M, a decrease of -50.14%. That is a compound annual growth rate of -15.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 45.53M | 25.03% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |